BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9116974)

  • 21. beta(1) and beta(2)-adrenergic receptor subtype effects in German shepherd dogs with inherited lethal ventricular arrhythmias.
    Sosunov EA; Gainullin RZ; Moise NS; Steinberg SF; Danilo P; Rosen MR
    Cardiovasc Res; 2000 Nov; 48(2):211-9. PubMed ID: 11054468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypothyroidism renders protection against lethal ventricular arrhythmias in a conscious canine model of sudden death.
    Venkatesh N; Lynch JJ; Uprichard AC; Kitzen JM; Singh BN; Lucchesi BR
    J Cardiovasc Pharmacol; 1991 Nov; 18(5):703-10. PubMed ID: 1723767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of the autonomic nervous system in modulating cardiac arrhythmias.
    Shen MJ; Zipes DP
    Circ Res; 2014 Mar; 114(6):1004-21. PubMed ID: 24625726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular biology and cellular mechanisms of Brugada and long QT syndromes in infants and young children.
    Antzelevitch C
    J Electrocardiol; 2001; 34 Suppl():177-81. PubMed ID: 11781953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of cardiac autonomic regulation and ventricular repolarization after off-pump coronary artery bypass grafting.
    Kalisnik JM; Avbelj V; Trobec R; Ivaskovic D; Vidmar G; Troise G; Gersak B
    Heart Surg Forum; 2006; 9(3):E661-7. PubMed ID: 16753938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Detection of patients at risk for sudden heart death by long-term ECG. The role of life-threatening ventricular arrhythmias].
    Hombach V; Höpp HW; Osterspey A; Winter U; Deutsch H; Hilger HH
    Herz; 1984 Feb; 9(1):6-25. PubMed ID: 6200415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long QT: good, bad or indifferent?
    Surawicz B; Knoebel SB
    J Am Coll Cardiol; 1984 Aug; 4(2):398-413. PubMed ID: 6145737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of AHR-12234 on cardiac transmembrane action potentials, in situ cardiac electrophysiology and experimental models for arrhythmias.
    Wu KM; Proakis AG; Hunter TL; Shanklin JR
    Arch Int Pharmacodyn Ther; 1989; 301():131-50. PubMed ID: 2624512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Possible electrophysiological mechanisms for lethal arrhythmias accompanying myocardial ischemia and infarction.
    Wit AL; Bigger JT
    Circulation; 1975 Dec; 52(6 Suppl):III96-115. PubMed ID: 1182986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. QTU prolongation and polymorphic ventricular tachyarrhythmias due to bradycardia-dependent early afterdepolarizations. Afterdepolarizations and ventricular arrhythmias.
    el-Sherif N; Zeiler RH; Craelius W; Gough WB; Henkin R
    Circ Res; 1988 Aug; 63(2):286-305. PubMed ID: 3396153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bradycardia-dependent triggered activity: relevance to drug-induced multiform ventricular tachycardia.
    Brachmann J; Scherlag BJ; Rosenshtraukh LV; Lazzara R
    Circulation; 1983 Oct; 68(4):846-56. PubMed ID: 6616779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The autonomic nervous system and cardiac arrhythmias.
    Esler M
    Clin Auton Res; 1992 Apr; 2(2):133-5. PubMed ID: 1638108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spatiotemporal patterns of early afterdepolarizations underlying abnormal T-wave morphologies in a tissue model of the Purkinje-ventricular system.
    Yuan M; Lian H; Li P
    PLoS One; 2023; 18(1):e0280267. PubMed ID: 36622850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What have we learned about the contribution of autonomic nervous system to human arrhythmia?
    Ogawa M; Zhou S; Tan AY; Fishbein MC; Lin SF; Chen LS; Chen PS
    Heart Rhythm; 2009 Aug; 6(8 Suppl):S8-11. PubMed ID: 19631911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study of ventricular repolarization in an experimental model of arterial hypertension associated with obesity].
    Pathak A; Verwaerde P; Galinier M; Pelat M; Couderc PP; Rouet P; Smih F; Buys S; Montastruc JL; Senard JM
    Arch Mal Coeur Vaiss; 2002; 95(7-8):651-5. PubMed ID: 12365074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular basis for QT dispersion.
    Antzelevitch C; Shimizu W; Yan GX; Sicouri S
    J Electrocardiol; 1998; 30 Suppl():168-75. PubMed ID: 9535495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship of ventricular tachycardia to sleep/wakefulness in a model of sudden cardiac death.
    Moïse NS; Brittain DD; Flahive WJ; Riccio ML; Ernst RS; Scarlett J; Mohammed HO; Morrison AR; Gilmour RF
    Pediatr Res; 1996 Aug; 40(2):344-50. PubMed ID: 8827788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comprehensive review and analysis of 25 years of data from an in vivo canine model of sudden cardiac death: implications for future anti-arrhythmic drug development.
    Billman GE
    Pharmacol Ther; 2006 Sep; 111(3):808-35. PubMed ID: 16483666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spontaneous stellate ganglion nerve activity and ventricular arrhythmia in a canine model of sudden death.
    Zhou S; Jung BC; Tan AY; Trang VQ; Gholmieh G; Han SW; Lin SF; Fishbein MC; Chen PS; Chen LS
    Heart Rhythm; 2008 Jan; 5(1):131-9. PubMed ID: 18055272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sympathetic neural and alpha-adrenergic modulation of arrhythmias.
    Rosen MR; Danilo P; Robinson RB; Shah A; Steinberg SF
    Ann N Y Acad Sci; 1988; 533():200-9. PubMed ID: 2844114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.